More on ROP
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $332.71 |
|
|||
| Open | $331.36 | ||||
| 52 Wk High | $195.93 | ||||
| 52 Wk Low | $155.79 | ||||
| Day High | $337.64 | ||||
| Day Low | $329.69 | ||||
| P/E | 62.38 | ||||
| EPS | $5.37 | ||||
| Volume | 1,127,680 | ||||
- DAT’s Convoy Platform now shows reload options before carriers book
- FDA grants priority review for Genentech's Tecentriq in stage III colon cancer
- FDA Grants Priority Review for Genentech’s Tecentriq for a Certain Type of Stage III Colon Cancer
- Roche's VENTANA MMR RxDx Panel companion diagnostic receives IVDR approval across multiple cancer types and therapies
- Nurix Therapeutics Announces Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology
- Roche rapidly develops a PCR test for Ebola within six days as rare Bundibugyo virus drives urgent need for detection
- FDA Accepts New Drug Application for Genentech’s Giredestrant in ER-Positive Early-Stage Breast Cancer, the First and Only Oral SERD With Positive Phase III Results in the Curative Setting
- Genentech to present obesity drug data at diabetes conference
- Genentech to Present New Data Advancing Its Obesity Portfolio at the American Diabetes Association’s 2026 Scientific Sessions
- Form 4 ROPER TECHNOLOGIES INC For: May 20 Filed by: ESTEVES IRENE M
Entities mentioned with ROP
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- Dividend | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Twitter | View Related Stories »
- Third Point LLC | View Related Stories »
- Show More...
